Provided by Tiger Trade Technology Pte. Ltd.

Harrow Health Inc

30.62
+0.27000.89%
Post-market: 30.950.3300+1.08%17:58 EDT
Volume:708.17K
Turnover:21.64M
Market Cap:1.15B
PE:-30.64
High:31.11
Open:30.09
Low:29.90
Close:30.35
52wk High:54.85
52wk Low:28.54
Shares:37.49M
Float Shares:28.93M
Volume Ratio:1.32
T/O Rate:2.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9993
EPS(LYR):-0.1400
ROE:-116.07%
ROA:-0.45%
PB:75.52
PE(LYR):-218.71

Loading ...

Harrow Re-Launches Verkazia® (Cyclosporine Ophthalmic Emulsion) 0.1% for Vernal Keratoconjunctivitis, Addressing Significant Unmet Need in Pediatric Eyecare

THOMSON REUTERS
·
Jun 10

Analysts Are Bullish on Top Healthcare Stocks: Harrow Health (HROW), GeneDx Holdings (WGS)

TIPRANKS
·
Jun 10

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 04

Harrow (HROW) Is Up 6.8% After Reaffirming 2026 Revenue Outlook Despite Wider Q1 Losses - What's Changed

Simply Wall St.
·
May 26

Harrow director Adrienne Graves acquires 1,000 common shares for $31,070

Reuters
·
May 19

Harrow director Lauren Silvernail acquires $31,000 in common shares

Reuters
·
May 19

Harrow CEO buys $302K, CFO buys $104.7K in common stock

TIPRANKS
·
May 15

Stock Track | Harrow Health Soars 6.93% in Pre-Market on Insider Buying by President and CFO

Stock Track
·
May 15

Harrow CEO Mark Baum buys 10,000 common shares for $302,000

Reuters
·
May 15

Harrow President, CFO Andrew Boll buys 3,500 shares worth $104,650

Reuters
·
May 15

Harrow price target lowered to $60 from $65 at B. Riley

TIPRANKS
·
May 14

Harrow Inc : B. Riley Cuts Target Price to $60 From $65

THOMSON REUTERS
·
May 14

B. Riley Adjusts Price Target on Harrow to $60 From $65, Maintains Buy Rating

MT Newswires Live
·
May 14

Stock Track | Harrow Health Soars 5.06% Intraday on Multiple Positive Analyst Ratings

Stock Track
·
May 14

Harrow price target lowered to $88 from $91 at Cantor Fitzgerald

TIPRANKS
·
May 13

Wohl & Fruchter probes Harrow for potential federal securities law violations

Reuters
·
May 13

Harrow Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
May 13

Harrow Health (HROW) Gets a Buy from Lake Street

TIPRANKS
·
May 13

Harrow Price Target Maintained With a $63.00/Share by BTIG

Dow Jones
·
May 13

Harrow (HROW) Q1 Loss Of US$27.6 Million Rekindles Profitability Concerns

Simply Wall St.
·
May 13